Diffusion MRI quality control and functional diffusion map results in ACRIN 6677/RTOG 0625: a multicenter, randomized, phase II trial of bevacizumab and chemotherapy in recurrent glioblastoma.

Int J Oncol · 2015 · PMC4383029 · PMID 25672376

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

trending toward significanceno p-value reported

P-values <0.05 were considered significant and P-values <0.1 were considered trending toward significance.

also in 580 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.